AI & ChatGPT searches , social queries for R13 DRUG
Search references for R13 DRUG. Phrases containing R13 DRUG
See searches and references containing R13 DRUG!
Search references for R13 DRUG. Phrases containing R13 DRUG
See searches and references containing R13 DRUG!R13 DRUG
Chemical compound
displayed a good drug profile in animal studies, it showed almost no conversion into tropoflavin in human liver microsomes. In contrast to R7, R13 is readily
R13_(drug)
Topics referred to by the same term
Television Review and Classification Board R13 (drug), an antidementia agent R-13 (missile), a Soviet missile system R13 (Rodalies de Catalunya), a regional
R13
Class of drugs used to treat malignant tumors
agents, also known as anticancer drugs or antineoplastic drugs, are medications used to treat malignant tumors. These drugs work through various mechanisms
Antineoplastic
Pharmaceutical compound
8-dihydroxyflavone, but it is more potent than earlier derivatives such as R13. It is under development as a potential treatment for neurodegenerative conditions
Braegen-02
Drugs that promote rapid and sustained neuroplasticity
ACD856 Other: scopolamine, isoflurane, tropoflavin (7,8-DHF, including R7 and R13), LY-341495, and elunetirom Substituted tryptamines: 6-MeO-DMT, DLX-159,
Psychoplastogen
Medication
ROS1-positive non-small cell lung cancer. In June 2024, the US Food and Drug Administration (FDA) expanded the indication to include the treatment of
Repotrectinib
Investigational antipsychotics
5-HT2A receptor antagonist, and other actions – schizophrenia [60] BrAD-R13 (R13; Braegen-01) – tropomyosin receptor kinase B (TrkB) agonist (tropoflavin
List of investigational antipsychotics
List_of_investigational_antipsychotics
List of pharmaceutical drugs under clinical development for treatment of depression
subunit-containing ionotropic glutamate NMDA receptor antagonist BrAD-R13 (R13; Braegen-01) – tropomyosin receptor kinase TrkB agonist Brexpiprazole (long-acting
List of investigational antidepressants
List_of_investigational_antidepressants
Mexican drug trafficker (1980–2020)
possible murders of the drug lord: Noé Castro (alias "R1"), Aréchiga Gamboa's right-hand man in Los Cabos; and a man known by his alias "R13". His most common
José_Rodrigo_Aréchiga_Gamboa
Chemical compound
prodrug of tropoflavin with greatly improved potency and pharmacokinetics, R13 (and, formerly, R7), is under development for the treatment of Alzheimer's
Tropoflavin
Protein or other substance that stimulates cellular proliferation
HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 (BrAD-R13, Braegen-01) SPV-400 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin
Growth_factor
South African businessman and tenderpreneur
hospital and three of the companies that were awarded contracts to the value of R13 538 292 in this syndicate are linked to Vusimuzi Matlala. In 2024, Matlala's
Cat_Matlala
Autoimmune endocrine disease
pathophysiology of Graves' disease". European Journal of Endocrinology. 168 (1): R13-8. doi:10.1530/EJE-12-0539. PMID 23027804. Tomer Y, Davies TF (February 1993)
Graves'_disease
Chemical compound
the preclinical stage of development. R7 was superseded by R13 because while R7 had a good drug profile in animals, it showed almost no conversion into tropoflavin
R7_(drug)
Plant-derived medication
tumor characteristics and relapse risk". Breast Cancer Research. 15 (1) R13. doi:10.1186/bcr3386. PMC 3672748. PMID 23421975. Ahern TP, Tamimi RM, Rosner
Digoxin
TrkA and TrkB positive modulator
sleep disorders, and traumatic brain injuries. It is taken by mouth. The drug potentiates the tropomyosin receptor kinases TrkA, TrkB, and TrkC with EC50Tooltip
ACD856
R10 titin-related LGMD R11 POMT1-related LGMD R12 anoctamin5-related LGMD R13 Fukutin-related LGMD R14 POMT2-related LGMD R15 POMGnT1-related LGMD R16
List of neuromuscular disorders
List_of_neuromuscular_disorders
Mexican drug lord (1949–2013)
October 1949 – 18 October 2013) was a Mexican drug lord and former leader of the Tijuana Cartel, a drug trafficking organization. He was the oldest of
Francisco Rafael Arellano Félix
Francisco_Rafael_Arellano_Félix
Chemical compound
investigational new drug that is being evaluated to treat neurodegenerative diseases such as Alzheimer's and Parkinson's disease. It is a pro-drug of the active
Fosgonimeton
Chemical compound
known as N-hexanoic-Tyr-Ile-(6) aminohexanoic amide) is an oligopeptide drug derived from angiotensin IV that binds with high affinity to hepatocyte growth
Dihexa
Pharmaceutical drug
family of fibroblast growth factor (FGF). The drug's target is the KGF receptor. Through the binding of this drug to the aforementioned receptor, Palifermin
Palifermin
Combination drug
272–. ISBN 978-1-60547-264-5. "Home". micromedexsolutions.com. "Sten". drugs.com. Sten — testosterone cypionate & propionate - Steroids World Archived
Testosterone propionate/testosterone cypionate/prasterone
Testosterone_propionate/testosterone_cypionate/prasterone
Medication
Trastuzumab deruxtecan, sold under the brand name Enhertu, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)
Trastuzumab_deruxtecan
Pharmaceutical compound
preclinical pharmacokinetics of SPV-400 have been studied and described. The drug is under development by Spave Science. As of August 2025, it is in the preclinical
SPV-400
Gene involved in the most common form of dwarfism
HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 (BrAD-R13, Braegen-01) SPV-400 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin
Fibroblast growth factor receptor 3
Fibroblast_growth_factor_receptor_3
Pharmaceutical drug
controls the leakage and swelling. Brolucizumab is approved by the US Food and Drug Administration (FDA) for use in ophthalmology. Brolucizumab successfully
Brolucizumab
Chemical compound
from this source, which is in the public domain. "Drug Trial Snapshot: Braftovi". U.S. Food and Drug Administration (FDA). 16 July 2018. Archived from
Encorafenib
Protein-coding gene in the species Homo sapiens
HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 (BrAD-R13, Braegen-01) SPV-400 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin
Fibroblast growth factor receptor 2
Fibroblast_growth_factor_receptor_2
Family of proteins that bind to fibroblast growth factors
Reclusa P, et al. (May 2017). "FGFR a promising druggable target in cancer: Molecular biology and new drugs" (PDF). Critical Reviews in Oncology/Hematology
Fibroblast growth factor receptor
Fibroblast_growth_factor_receptor
2012 film by Seth MacFarlane
In Australia, Ted was rated MA 15+, whereas in New Zealand, it was rated R13 for its theatrical release and R16 for the extended DVD/Blu-ray release.
Ted_(film)
Chemical compound
of the Sprycel drug label. In studies between 2009 and 2017 dasatinib-induced PAH was initiated between 0.3 and 74 months of daily drug usage at doses
Dasatinib
Curling played by people in wheelchairs
Curling. Archived from the original on 12 March 2010. Retrieved 19 March 2018. R13. WHEELCHAIR CURLING ... (h) For World Curling wheelchair competitions, each
Wheelchair_curling
Medication
4–5 years supply of the drug. Roche has agreed[when?] with Emcure in India to make an affordable version of this cancer drug available to the Indian market
Trastuzumab
Medication and naturally occurring steroid hormone
Testosterone levels may decline gradually with age. The United States Food and Drug Administration (FDA) stated in 2015 that neither the benefits nor the safety
Testosterone_(medication)
Medication
trafermin is a potent agonist of the FGFR1, FGFR2, FGFR3, and FGFR4. The drug has been marketed in Japan since June 2001.[citation needed] Han SK (15 September
Trafermin
Chemical compound
Boehringer Ingelheim, under the trade name Marquis (15% w/w ponazuril), is a drug currently approved for the treatment of equine protozoal myeloencephalitis
Ponazuril
American actress (born 1970)
Race for What Pitt Calls – Our Highest Honour", Globe & Mail, Toronto, p. R13 Viera, Lauren (December 21, 2008). "The curious case of Taraji P. Henson"
Taraji_P._Henson
Pharmaceutical drug
approved for medical use in the United States in March 2023. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Trofinetide
Trofinetide
Chemical compound
received U.S. Food and Drug Administration (FDA) approval for use for idiopathic pulmonary fibrosis in 2014 – one of only two drugs available for treating
Nintedanib
Chemical compound
and the New Drug Application was withdrawn. In June 2018, it was approved for the treatment of certain melanomas by the U.S. Food and Drug Administration
Binimetinib
Tricyclic antidepressant
in the late 1950s by scientists at Merck and approved by the US Food and Drug Administration (FDA) in 1961. It is on the World Health Organization's List
Amitriptyline
Cancer treatment medicine
Sorafenib, sold under the brand name Nexavar, is a kinase inhibitor drug approved for the treatment of primary kidney cancer (advanced renal cell carcinoma)
Sorafenib
Cancer medication
(trade names Tykerb and Tyverb marketed by Novartis) is an orally active drug for breast cancer and other solid tumours. It is a dual tyrosine kinase inhibitor
Lapatinib
Drug typically used in cancer treatment
A tyrosine kinase inhibitor (TKI) is a pharmaceutical drug that inhibits tyrosine kinases. Tyrosine kinases are enzymes responsible for the activation
Tyrosine_kinase_inhibitor
Protein-coding gene in humans
humanised monoclonal antibody targeted at CCR4 and is an investigational drug for CTCL. GRCh38: Ensembl release 89: ENSG00000183813 – Ensembl, May 2017
CCR4
Targeted cancer drug
Melanoma cells without these mutations are not inhibited by vemurafenib; the drug paradoxically stimulates normal BRAF and may promote tumor growth in such
Vemurafenib
Medication
Philadelphia chromosome-positive acute lymphoblastic leukemia. The US Food and Drug Administration (FDA) issued a partial clinical hold on new trial enrollment
Ponatinib
ALK inhibitor for treatment of non-small-cell lung cancer
(INN, trade name Zykadia /zaɪˈkeɪdiːə/ zy-KAY-dee-ə) is a prescription-only drug used for the treatment of non-small cell lung cancer (NSCLC). It was developed
Ceritinib
Chemical compound
person to be treated with the drug. The drug received FDA approval in May 2001, only two and a half years after the new drug application was submitted. On
Imatinib
Monoclonal antibody
in May 2021, and in the European Union in December 2021. The US Food and Drug Administration considers it to be a first-in-class medication. Amivantamab
Amivantamab
Chemical compound
treatment with radioactive iodine (radioiodine). In May 2016, the US Food and Drug Administration (FDA) approved it (in combination with everolimus) for the
Lenvatinib
TKI inhibitor used for cancer treatment
entrectinib has orphan drug designation and rare pediatric disease designation for the treatment of neuroblastoma and orphan drug designation for treatment
Entrectinib
Pharmaceutical drug
cell cancer of the head and neck. Cetuximab was approved by the US Food and Drug Administration (FDA) in March 2006, for use in combination with radiation
Cetuximab
Protein and coding gene in humans
Neurotrophin-4 (NT-4) Norwogonin (5,7,8-THF) R7 (prodrug of tropoflavin) R13 (BrAD-R13; Braegen-01; prodrug of tropoflavin) SPV-400 TDP6 Tropoflavin (7,8-DHF)
Tropomyosin_receptor_kinase_B
Pharmaceutical compound
Linsitinib is an experimental drug candidate for the treatment of various types of cancer. It is an inhibitor of the insulin receptor and of the insulin-like
Linsitinib
Medication
Sandoz's filgrastim-sndz (Zarxio), obtained the approval of the US Food and Drug Administration (FDA) as a biosimilar. This was the first product to be passed
Filgrastim
Experimental drug for neurodegenerative disorders
government-approved drug is unclear. It is only available by prescription from a physician. As of October 2020, cerebrolysin was not an approved drug in the United
Cerebrolysin
Pharmaceutical drug
European Union in July 2017, and in the United States in 2018. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication. Cenegermin
Cenegermin
Medication
endorsement from the drug. The June 2011 meeting of the FDA's oncologic drug advisory committee was the last step in an appeal by the drug's maker. The committee
Bevacizumab
Medication
2024. Retrieved 19 December 2024. "Summary Basis of Decision for Fruzaqla". Drug and Health Products Portal. 2 January 2025. Retrieved 25 January 2025. "Fruzaqla
Fruquintinib
Novel by Sue Grafton
personal history since it involves her second ex-husband, jazz musician and drug addict Daniel Wade, who was only briefly addressed in "C" is for Corpse.
"E"_Is_for_Evidence
Protein that stimulates red blood cell production
to be avoided. rhEPO has been used illicitly as a performance-enhancing drug. It can often be detected in blood, due to slight differences from the endogenous
Erythropoietin
Corticosteroid medication
Dexamethasone intravitreal steroid implants have been approved by the US Food and Drug Administration (FDA) to treat ocular conditions such as diabetic macular
Dexamethasone
Synthetic protein
PMID 21281823. Mario Thevis (13 December 2010). Mass Spectrometry in Sports Drug Testing: Characterization of Prohibited Substances and Doping Control Analytical
IGF-1_LR3
System used for the classification of video games into suitability-related groups
with an M label are more suitable for mature audiences 16 years and over. R13: Restricted to persons 13 years and over. R15: Restricted to persons 15 years
Video game content rating system
Video_game_content_rating_system
Chemical compound
in April 2020, and in the European Union in June 2021. The U.S. Food and Drug Administration considers it to be a first-in-class medication. Selumetinib
Selumetinib
Kinase inhibitor for treatment of non-small-cell lung cancer
lymphoma kinase inhibitor. In 2015, the US Food and Drug Administration granted lorlatinib orphan drug status for the treatment of anaplastic lymphoma kinase
Lorlatinib
Mammalian protein found in humans
compared with other identifiably genetically distinct breast cancers; however, drug agents targeting HER2 have significantly and positively altered the otherwise
HER2
Primary government agency responsible for biomedical and public health research in the US
Program, not renewable and limited to 2 years, with a maximum of $50k/year. R13, NIH Support for Conferences and Scientific Meetings R15, NIH Academic Research
NIH_grant
Anticancer medication
medication used for the treatment of melanoma and glioma. It is a MEK inhibitor drug with anti-cancer activity. It inhibits MEK1 and MEK2. It is taken by mouth
Trametinib
Recombinant human monoclonal antibody
Medscape.com. Retrieved 2019-09-28. "Necitumumab". Approved Drugs. U.S. Food and Drug Administration. Archived from the original on 2017-01-11. Retrieved
Necitumumab
ALK inhibitor for treatment of non-small-cell lung cancer
(NSCLC) as detected by an FDA-approved test. In April 2024, the US Food and Drug Administration (FDA) expanded the indication of alectinib to include adjuvant
Alectinib
Combination drug
Can Be Administered At Home By Health Care Professional". U.S. Food and Drug Administration (Press release). 29 June 2020. Archived from the original
Pertuzumab/trastuzumab/hyaluronidase
Pertuzumab/trastuzumab/hyaluronidase
Pharmaceutical drug
October 2012. Retrieved 28 October 2012. "Drug Approval Package: Lucentis (Ranibizumab) NDA #125156". U.S. Food and Drug Administration (FDA). 26 September 2006
Ranibizumab
Medication for treatment of non-small-cell lung cancer
survival (PFS) by 29%, when compared to chemotherapy alone. The U.S. Food and Drug Administration (FDA) approved erlotinib for the treatment of locally advanced
Erlotinib
Anti-cancer medication
Retrieved December 11, 2023. "Drug Approval Package: Tafinlar (dabrafenib) Capsules NDA #202806". U.S. Food and Drug Administration (FDA). December 24
Dabrafenib
Medication which blocks growth of blood vessels
[clarification needed] Bergers and Hanahan concluded in 2008 that anti-VEGF drugs can show therapeutic efficacy in mouse models of cancer and in an increasing
Anti-VEGF
Monoclonal antibody
for medical use in the United States in February 2021. The U.S. Food and Drug Administration considers it to be a first-in-class medication. Regeneron
Evinacumab
Pharmaceutical compound
Ancestim Clinical data AHFS/Drugs.com International Drug Names Routes of administration s.c. injection only, premedication with H1 and H2 antihistamines
Ancestim
Pharmaceutical drug
inhibition of VEGF-mediated tumor angiogenesis. In April 2014, the US Food and Drug Administration (FDA) approved ramucirumab as a single-agent treatment for
Ramucirumab
Chemical compound
Tesevatinib (KD019, XL647) is an experimental drug proposed for use in kidney cancer and polycystic kidney disease. The drug was first developed by Exelixis, Inc
Tesevatinib
Chemical compound
cabozantinib in its capsule formulation was approved by the US Food and Drug Administration (FDA) under the name Cometriq for treating people with medullary
Cabozantinib
Chemical compound
receptor for treating a variety of CNS disorders". CNS & Neurological Disorders Drug Targets. 12 (7): 1066–77. doi:10.2174/18715273113129990089. PMID 23844685
Eutropoflavin
Pharmaceutical drug
said that it intended to continue developing it in combination with other drugs for ovarian cancer. In 2007, Genentech dropped the trade name Omnitarg.
Pertuzumab
Rates the suitability of movies to its audience
and over unless accompanied by a Parent/Guardian (online content only). R13: Restricted to persons 13 years and over. R15: Restricted to persons 15 years
Motion picture content rating system
Motion_picture_content_rating_system
Pharmaceutical drug
HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 (BrAD-R13, Braegen-01) SPV-400 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin
Alacizumab_pegol
Pharmaceutical drug
Trastuzumab emtansine, sold under the brand name Kadcyla, is an antibody-drug conjugate consisting of the humanized monoclonal antibody trastuzumab (Herceptin)
Trastuzumab_emtansine
Medication for macular degeneration
effects of the drug on the breastfed infant, or the effects of the drug on milk production. However, the drug company states that many drugs are transferred
Faricimab
Foundation, the Pfizer Foundation, the United States Public Health Service (R13-MH066849, R01-MH069864, and R01 DA016558), the Fogarty International Center
World Mental Health survey initiative
World_Mental_Health_survey_initiative
Medication used for cancer
approval for use of their drugs as initial therapies. Currently the TK inhibitors are approved for use only after other drugs fail.[citation needed] In
Gefitinib
Combination cancer medication
approved for medical use in the United States in May 2025. The US Food and Drug Administration considers it to be a first-in-class medication. Avutometinib/defactinib
Avutometinib/defactinib
Chemical compound
Regorafenib was restored to the list of treatments funded by the English Cancer Drugs Fund. In February 2013 the US FDA expanded the approved use to treat patients
Regorafenib
Chemical compound
photosensitivity, and pyrexia. Cobimetinib was granted orphan drug designation by the US Food and Drug Administration (FDA) for melanoma with BRAFV600 mutation
Cobimetinib
ALK inhibitor for treatment of non-small-cell lung cancer
filed an investigational new drug (IND) application to the US FDA on August 29, 2016. In 2016, brigatinib was granted orphan drug status by the FDA for treatment
Brigatinib
Protein involved in blood vessel growth
vascular disease in the retina of the eye and other parts of the body. Drugs such as aflibercept, bevacizumab, ranibizumab, and pegaptanib can inhibit
Vascular endothelial growth factor
Vascular_endothelial_growth_factor
Monoclonal antibody
people with non-myeloid malignancies receiving myelosuppressive anti-cancer drugs associated with a clinically significant incidence of febrile neutropenia;
Pegfilgrastim
Chemical compound
FDA-Approved Drugs". U.S. Food and Drug Administration (FDA). Retrieved 28 January 2020.[dead link] "Drug Trial Snapshot: Tepezza". U.S. Food and Drug Administration
Teprotumumab
Chemical compound
HIOC LM22A-4 N-Acetylserotonin NT-3 NT-4 Norwogonin (5,7,8-THF) R7 R13 (BrAD-R13, Braegen-01) SPV-400 TDP6 Antagonists: ANA-12 Cyclotraxin B Gossypetin
7,8,3'-Trihydroxyflavone
Monoclonal antibody
Williams R (December 2013). "Discontinued drugs in 2012: oncology drugs". Expert Opinion on Investigational Drugs. 22 (12): 1627–1644. doi:10.1517/13543784
Flanvotumab
Chemical compound
NSCLC patients called Lux-Lung 5 began with this drug. Fall 2010 interim results suggested the drug extended progression-free survival threefold compared
Afatinib
R13 DRUG
R13 DRUG
Male
Hebrew
(×ֲבִימָ×ֵל) Hebrew name ABIYMA'EL means "my father is El (God)." In the bible, this is the name of Joktan's ninth son (of 13), a descendant of Shem.
Male
Greek
(ΚαÏπός) Greek name KARPOS means "fruit." In mythology, this is the name of a son of the nymph Khloris and the god Zephyros. In the bible, it is the name of a Christian at Troas mentioned in the second epistle of Timothy (2 Ti. 4:13).
Surname or Lastname
Jewish (Ashkenazic)
Jewish (Ashkenazic) : occupational name for a cantor in a synagogue, from Yiddish zinger ‘singer’.English : variant of Sanger 2, in fact a Middle English recoinage from the verb sing(en) ‘to sing’.German : variant of Sänger (see Sanger 1) in the sense of ‘poet’.Isaac Merrit Singer, inventor of the eponymous sewing machine, was born in 1811 in Pittstown, NY, the son of German immigrant Adam Reisinger. He had five wives and fathered 24 children. Singer, who incorporated his company as the Singer Manufacturing Company in 1864, left a fortune worth $13 million to his various heirs.
Surname or Lastname
English
English : occupational name for the servant of a parish priest or parson, or a patronymic denoting the child of a parson, from the possessive case of Middle English persone, parsoun (see Parson).English : many early examples are found with prepositions (e.g. Ralph del Persones 1323); these are habitational names, with the omission of house, hence in effect occupational names for servants employed at the parson’s house.Irish : usually of English origin (see above), but sometimes a reduced Anglicized form of Gaelic Mac an Phearsain, which is of Highland Scottish origin (see McPherson).Members of an Irish family called Parsons wre twice created earl of Rosse, first in 1718 and again in 1806. They settled in Ireland c.1590, when two brothers, William and Laurence Parsons, were granted large estates. Birr Castle, Parsonstown, became the family seat. Samuel Holden Parsons, born Lyme, CT, in 1737 was a Connecticut legislator and revolutionary war officer. Theophilius Parsons (1750–1813) was born in Byfield, MA, and was chief justice of the MA supreme court (1806–13); his son, also Theophilius, was a professor at Harvard Law School (1848–1869).
Male
Polish
Pet form of Polish Andrzej, DRUGI means "man; warrior."
Surname or Lastname
English, German, Dutch, and Jewish
English, German, Dutch, and Jewish : from the personal name Michael, ultimately from Hebrew Micha-el ‘Who is like God?’. This was borne by various minor Biblical characters and by one of the archangels, the protector of Israel (Daniel 10:13, 12:1; Rev. 12:7). In Christian tradition, Michael was regarded as the warrior archangel, conqueror of Satan, and the personal name was correspondingly popular throughout Europe, especially in knightly and military families. In English-speaking countries, this surname is also found as an Anglicized form of several Greek surnames having Michael as their root, for example Papamichaelis ‘Michael the priest’ and patronymics such as Michaelopoulos.
Male
English
Anglicized form of Hebrew Abiyma'el, ABIMAEL means "my father is El (God)." In the bible, this is the name of Joktan's ninth son (of 13), a descendant of Shem.
Male
Spanish
Spanish name derived from Latin Pastor, PASTOR means "shepherd." St. Pastor was a 9-year-old boy who along with his 13-year-old brother, Justus, was martyred at Alcalá de Henares in the early 4th century.
Boy/Male
German
Strong.
R13 DRUG
R13 DRUG
R13 DRUG
R13 DRUG
R13 DRUG
R13 DRUG
R13 DRUG